Literature DB >> 18389334

The K121Q polymorphism of ENPP1 and peripheral arterial disease.

Philipp Eller1, Wilfried Schgoer, Thomas Mueller, Ivan Tancevski, Egon Demetz, Kristina Duwensee, Andreas Ritsch, Meinhard Haltmayer, Josef R Patsch.   

Abstract

The K121Q variant of the ectonucleotide pyrophosphatase/ phosphodiesterase 1 (ENPP1) gene is associated with obesity, insulin resistance, and early myocardial infarction. Therefore, we hypothesized that the K121Q polymorphism might also be associated with an increased risk for peripheral arterial disease. Four hundred patients with peripheral arterial disease and 400 controls matched for sex and age (+/- 2 years) were genotyped cross-sectionally for the K121Q single nucleotide polymorphism of the ENPP1 gene. The frequency for the 121Q allele was 0.25 both in patients with peripheral arterial disease and in controls (P = 0.75). Subgroup analysis revealed association of the ENPP1 121QQ genotype with higher glycohemoglobin A1C levels (P = 0.001) and earlier onset of peripheral arterial disease (P = 0.003) in the cohort of nonsmokers. Whereas the K121Q genotype of the ENPP1 gene is not associated with presence of peripheral arterial disease in the whole Linz Peripheral Arterial Disease population, it is associated with type 2 diabetes mellitus and earlier onset of peripheral arterial disease in the subgroup of nonsmoking patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18389334     DOI: 10.1007/s00380-007-1014-9

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  17 in total

Review 1.  Atherosclerotic Vascular Disease Conference: Writing Group III: pathophysiology.

Authors:  David P Faxon; Valentin Fuster; Peter Libby; Joshua A Beckman; William R Hiatt; Robert W Thompson; James N Topper; Brian H Annex; John H Rundback; Rosalind P Fabunmi; Rose Marie Robertson; Joseph Loscalzo
Journal:  Circulation       Date:  2004-06-01       Impact factor: 29.690

2.  Whole-body three-dimensional contrast-enhanced magnetic resonance (MR) angiography with parallel imaging techniques on a multichannel MR system for the detection of various systemic arterial diseases.

Authors:  Jiang Lin; Bin Chen; Jian-Hua Wang; Meng-Su Zeng; Yi-Xiang Wang
Journal:  Heart Vessels       Date:  2006-11-27       Impact factor: 2.037

3.  The K121Q polymorphism in the plasma cell membrane glycoprotein 1 gene predisposes to early myocardial infarction.

Authors:  Georg Endler; Christine Mannhalter; Heike Sunder-Plassmann; Martin Schillinger; Alexandra Klimesch; Markus Exner; Sonja Kapiotis; Susanne Meier; Freja Kunz; Elisabeth Raiger; Kurt Huber; Oswald Wagner; Raute Sunder-Plassmann
Journal:  J Mol Med (Berl)       Date:  2002-11-13       Impact factor: 4.599

4.  Recommended standards for reports dealing with lower extremity ischemia: revised version.

Authors:  R B Rutherford; J D Baker; C Ernst; K W Johnston; J M Porter; S Ahn; D N Jones
Journal:  J Vasc Surg       Date:  1997-09       Impact factor: 4.268

5.  Factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations are not associated with chronic limb ischemia: the Linz Peripheral Arterial Disease (LIPAD) study.

Authors:  Thomas Mueller; Renate Marschon; Benjamin Dieplinger; Dieter Haidinger; Alfons Gegenhuber; Werner Poelz; Gerald Webersinke; Meinhard Haltmayer
Journal:  J Vasc Surg       Date:  2005-05       Impact factor: 4.268

6.  Plasma cell membrane glycoprotein PC-1. cDNA cloning of the human molecule, amino acid sequence, and chromosomal location.

Authors:  M F Buckley; K A Loveland; W J McKinstry; O M Garson; J W Goding
Journal:  J Biol Chem       Date:  1990-10-15       Impact factor: 5.157

7.  Chondrogenesis mediated by PPi depletion promotes spontaneous aortic calcification in NPP1-/- mice.

Authors:  Kristen Johnson; Monika Polewski; Deborah van Etten; Robert Terkeltaub
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-12-29       Impact factor: 8.311

8.  Membrane glycoprotein PC-1 and insulin resistance in non-insulin-dependent diabetes mellitus.

Authors:  B A Maddux; P Sbraccia; S Kumakura; S Sasson; J Youngren; A Fisher; S Spencer; A Grupe; W Henzel; T A Stewart
Journal:  Nature       Date:  1995-02-02       Impact factor: 49.962

9.  Mutation in Npps in a mouse model of ossification of the posterior longitudinal ligament of the spine.

Authors:  A Okawa; I Nakamura; S Goto; H Moriya; Y Nakamura; S Ikegawa
Journal:  Nat Genet       Date:  1998-07       Impact factor: 38.330

10.  Variants of ENPP1 are associated with childhood and adult obesity and increase the risk of glucose intolerance and type 2 diabetes.

Authors:  David Meyre; Nabila Bouatia-Naji; Agnès Tounian; Chantal Samson; Cécile Lecoeur; Vincent Vatin; Maya Ghoussaini; Christophe Wachter; Serge Hercberg; Guillaume Charpentier; Wolfgang Patsch; François Pattou; Marie-Aline Charles; Patrick Tounian; Karine Clément; Béatrice Jouret; Jacques Weill; Betty A Maddux; Ira D Goldfine; Andrew Walley; Philippe Boutin; Christian Dina; Philippe Froguel
Journal:  Nat Genet       Date:  2005-07-17       Impact factor: 38.330

View more
  2 in total

1.  Npp1 promotes atherosclerosis in ApoE knockout mice.

Authors:  Yvonne Nitschke; Gabriele Weissen-Plenz; Robert Terkeltaub; Frank Rutsch
Journal:  J Cell Mol Med       Date:  2011-11       Impact factor: 5.310

2.  Expression of NPP1 is regulated during atheromatous plaque calcification.

Authors:  Yvonne Nitschke; Simone Hartmann; Giovanni Torsello; Rüdiger Horstmann; Harald Seifarth; Gabriele Weissen-Plenz; Frank Rutsch
Journal:  J Cell Mol Med       Date:  2011-02       Impact factor: 5.310

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.